Jan Soerensen

2.1k total citations
39 papers, 988 citations indexed

About

Jan Soerensen is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Jan Soerensen has authored 39 papers receiving a total of 988 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 20 papers in Immunology and 18 papers in Oncology. Recurrent topics in Jan Soerensen's work include Hematopoietic Stem Cell Transplantation (22 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (13 papers). Jan Soerensen is often cited by papers focused on Hematopoietic Stem Cell Transplantation (22 papers), Immune Cell Function and Interaction (18 papers) and CAR-T cell therapy research (13 papers). Jan Soerensen collaborates with scholars based in Germany, Switzerland and Denmark. Jan Soerensen's co-authors include Thomas Klingebiel, Peter Bader, Ulrike Koehl, Dirk Schwabe, Sabine Huenecke, Jakob Passweg, Ruth Esser, Andrea Jarisch, Melanie Bremm and Eva Rettinger and has published in prestigious journals such as Blood, PLoS ONE and Diabetes Care.

In The Last Decade

Jan Soerensen

38 papers receiving 971 citations

Peers

Countries citing papers authored by Jan Soerensen

Since Specialization

Citations

This map shows the geographic impact of Jan Soerensen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Soerensen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Soerensen more than expected).

Fields of papers citing papers by Jan Soerensen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Soerensen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Soerensen. The network helps show where Jan Soerensen may publish in the future.

Co-authorship network of co-authors of Jan Soerensen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Soerensen. A scholar is included among the top collaborators of Jan Soerensen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Soerensen. Jan Soerensen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Donor‐type red blood cell transfusion to deplete isoagglutinins prior to allogeneic stem cell transplantation from ABO major incompatible bone marrow donors 2023 ·British Journal of Haematology ·Andrea Jarisch, Emilia Salzmann‐Manrique, Jan Soerensen, (unknown), Eva Rettinger, André Willasch, Shahrzad Bakhtiar, Dieter Klarmann, Susanne Bräuninger, (unknown), (unknown), Martin Hutter, Thomas Klingebiel, Jan‐Henning Klusmann, Peter Bader, Halvard Bönig	0
2	Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia 2022 ·Transplantation and Cellular Therapy ·Andrea Jarisch, Eliza Wiercinska, Sabine Huenecke, Melanie Bremm, (unknown), (unknown), Eva Rettinger, Jan Soerensen, (unknown), Jan‐Henning Klusmann, Sandra Ciesek, Halvard Bönig, Peter Bader	11
3	Depletion of CD45RA+ T cells: Advantages and disadvantages of different purification methods 2021 ·Journal of Immunological Methods ·Melanie Bremm, (unknown), (unknown), (unknown), (unknown), (unknown), Halvard Bönig, Richard Schäfer, Eva Rettinger, Matthias Merker, Sebastian Bremm, (unknown), Thomas Klingebiel, Jan Soerensen, Peter Bader, Sabine Huenecke	2
4	Clearance of Hematologic Malignancies by Allogeneic Cytokine-Induced Killer Cell or Donor Lymphocyte Infusions 2019 ·Biology of Blood and Marrow Transplantation ·Matthias Merker, Emilia Salzmann‐Manrique, (unknown), Sabine Huenecke, Melanie Bremm, Shahrzad Bakhtiar, André Willasch, Andrea Jarisch, Jan Soerensen, Ansgar Schulz, Roland Meisel, Gesine Bug, Halvard Bönig, Thomas Klingebiel, Peter Bader, Eva Rettinger	32
5	Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial 2018 ·Bone Marrow Transplantation ·Matthias Merker, Michael T. Meister, Eva Rettinger, Andrea Jarisch, Jan Soerensen, André Willasch, Sabine Huenecke, (unknown), Melanie Bremm, Emilia Salzmann‐Manrique, (unknown), Claudia Rössig, Bernhard Kremens, Ewa Kościelniak, Thomas Klingebiel, Peter Bader	7
6	Development of Three Different NK Cell Subpopulations during Immune Reconstitution after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation: Prognostic Markers in GvHD and Viral Infections 2017 ·Frontiers in Immunology ·Sabine Huenecke, (unknown), Ruth Esser, (unknown), Emilia Salzmann‐Manrique, (unknown), (unknown), (unknown), Shahrzad Bakhtiar, Christoph Königs, Andrea Jarisch, Jan Soerensen, Evelyn Ullrich, Thomas Klingebiel, Peter Bader, Melanie Bremm	26
7	In-vitro influence of mycophenolate mofetil (MMF) and Ciclosporin A (CsA) on cytokine induced killer (CIK) cell immunotherapy 2016 ·Journal of Translational Medicine ·Melanie Bremm, Sabine Huenecke, (unknown), (unknown), Andrea Quaiser, Halvard Bönig, Jan Soerensen, Thomas Klingebiel, Eva Rettinger, Peter Bader, (unknown)	8
8	Treatment of relapse after allogeneic stem cell transplantation in children and adolescents with ALL: the Frankfurt experience 2016 ·Bone Marrow Transplantation ·André Willasch, Emilia Salzmann‐Manrique, (unknown), (unknown), Joerg Faber, (unknown), Hermann Kreyenberg, (unknown), Sabine Huenecke, (unknown), Melanie Bremm, (unknown), Matthias Merker, Evelyn Ullrich, Shahrzad Bakhtiar, Eva Rettinger, Andrea Jarisch, Jan Soerensen, Thomas Klingebiel, Peter Bader	18
9	Pre-Emptive Immunotherapy for Clearance of Molecular Disease in Childhood Acute Lymphoblastic Leukemia after Transplantation 2016 ·Biology of Blood and Marrow Transplantation ·Eva Rettinger, Matthias Merker, Emilia Salzmann‐Manrique, Hermann Kreyenberg, (unknown), Matthias Dürken, Jörg Faber, Sabine Huenecke, (unknown), Melanie Bremm, André Willasch, Shahrzad Bakhtiar, Andrea Jarisch, Jan Soerensen, Thomas Klingebiel, Peter Bader	23
10	Interleukin-2-stimulated natural killer cells are less susceptible to mycophenolate mofetil than non-activated NK cells: possible consequences for immunotherapy 2014 ·Cancer Immunology Immunotherapy ·Claudia Brehm, Sabine Huenecke, Ruth Esser, Stephan Kloeß, Andrea Quaiser, (unknown), (unknown), Jan Soerensen, Jakob Passweg, Thomas Klingebiel, Dirk Schwabe, Peter Bader, Ulrike Koehl	27
11	IL-2 Stimulated but Not Unstimulated NK Cells Induce Selective Disappearance of Peripheral Blood Cells: Concomitant Results to a Phase I/II Study 2011 ·PLoS ONE ·Claudia Brehm, Sabine Huenecke, Andrea Quaiser, Ruth Esser, Melanie Bremm, Stephan Kloeß, Jan Soerensen, Hermann Kreyenberg, Christian Seidl, P. S. A. Becker, Heiko Mühl, Thomas Klingebiel, Peter Bader, Jakob Passweg, Dirk Schwabe, Ulrike Koehl	71
12	Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells 2011 ·Best Practice & Research Clinical Haematology ·Peter Bader, Jan Soerensen, Andrea Jarisch, (unknown), (unknown), Jörg Faber, Matthias Dürken, (unknown), André Willasch, Ruth Esser, Halvard Bönig, Ulrike Koehl, Thomas Klingebiel	36
13	IL-2−driven Regulation of NK Cell Receptors With Regard to the Distribution of CD16+ and CD16− Subpopulations and In Vivo Influence After Haploidentical NK Cell Infusion 2010 ·Journal of Immunotherapy ·Sabine Huenecke, Stefanie Zimmermann, Stephan Kloeß, Ruth Esser, Andrea Brinkmann, Lars Tramsen, (unknown), (unknown), Christian Seidl, Torsten Tonn, Angelika Eggert, Alexander Schramm, Peter Bader, Thomas Klingebiel, Thomas Lehrnbecher, Jakob Passweg, Jan Soerensen, Dirk Schwabe, Ulrike Koehl	77
14	IL‐2‐activated haploidentical NK cells restore NKG2D‐mediated NK‐cell cytotoxicity in neuroblastoma patients by scavenging of plasma MICA 2010 ·European Journal of Immunology ·Stephan Kloeß, Sabine Huenecke, (unknown), Ruth Esser, Joachim Koch, Claudia Brehm, Jan Soerensen, Tanja Gardlowski, Andrea Brinkmann, Peter Bader, Jakob Passweg, Thomas Klingebiel, Dirk Schwabe, Ulrike Koehl	72
15	The most frequentDCLRE1C(ARTEMIS) mutations are based on homologous recombination events 2009 ·Human Mutation ·Ulrich Pannicke, Manfred Hönig, Ilka Schulze, Jan Rohr, Gitta Anne Heinz, (unknown), (unknown), (unknown), Markus G. Seidel, Susanne Matthes‐Martin, Jan Soerensen, Johann Greil, Daniel Stachel, Bernd H. Belohradsky, Michael H. Albert, Ansgar Schulz, Stephan Ehl, Wilhelm Friedrich, Klaus Schwarz	33
16	Enrichment of cell subpopulations applying automated MACS technique: purity, recovery and applicability for PCR-based chimerism analysis 2009 ·Bone Marrow Transplantation ·André Willasch, (unknown), Gerrit Weber, Selim Kuçi, Gisbert Schneider, Jan Soerensen, Andrea Jarisch, Eva Rettinger, Ulrike Koehl, Thomas Klingebiel, Hermann Kreyenberg, Peter Bader	32
17	Reconstitution of Cytomegalovirus Specific T Cells after Pediatric Allogeneic Stem Cell Transplantation: Results from a Pilot Study Using a Multi-Allele CMV Tetramer Group 2008 ·Klinische Pädiatrie ·Ulrike Koehl, (unknown), (unknown), (unknown), Jan Soerensen, Peter Bader, H. W. Doerr, Wolfgang Preiser, Eva M. Weissinger, T. Klingebiel, Hans Martin, Thomas Lehrnbecher	12
18	ISHAGE-based single-platform flowcytometric analysis for measurement of absolute viable T cells in fresh or cryopreserved products: CD34/CD133 selected or CD3/CD19 depleted stem cells, DLI and purified CD56+CD3− NK cells 2007 ·International Journal of Hematology ·Ulrike Koehl, Konrad Bochennek, R. Esser, Andrea Brinkmann, (unknown), (unknown), Jan Soerensen, Peter Bader, Dirk Schwabe, Thomas Klingebiel, Johannes Fischer, Stefanie Zimmermann	21
19	Meningitis Due to Multiple-ResistantPenicillin- and Cefotaxime-Intermediate Streptococcus pneumoniae in a GermanChild after Bone Marrow Transplantation 2003 ·Infection ·Horst Buxmann, Jan Soerensen, Ulrike Koehl, Dirk Schwabe, Thomas Klingebiel, Ralf René Reinert, (unknown)	5
20	Tecelac as antithymocyte globulin in conditioning for childhood allogeneic stem cell transplantation 2002 ·Bone Marrow Transplantation ·Stefanie Zimmermann, Thomas Klingebiel, Ulrike Koehl, Jan Soerensen, Dirk Schwabe	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact